Journal of Nuclear Medicine: 62 (12)

December 1, 2021; Volume 62,Issue 12

Cover image

FEATURED ARTICLE

Dynamic ¹⁸F-FPCIT PET: Quantifi cation of Parkinson Disease Metabolic Networks and Nigrostriatal Dopaminergic Dysfunction in a Single Imaging Session. Shichun Peng et al. See page 1775.

In this issue

Issue highlights

Dynamic ¹⁸F-FPCIT PET: Quantification of Parkinson Disease Metabolic Networks and Nigrostriatal Dopaminergic Dysfunction in a Single Imaging Session
Improved ²²³Ra Therapy with Combination Epithelial Sodium Channel Blockade

First-in-Human Assessment of ¹¹C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA
Fibroblast Activation Protein–Targeted PET/CT with ⁶⁸Ga-FAPI for Imaging IgG4-Related Disease: Comparison to ¹⁸F-FDG PET/CT

More...

Main menu

User menu

Search

Table of Contents

Cover image

In this issue

Issue highlights

Jump to